Rifadin IV 600 mg/10mL
rifampin · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Sanofi-Aventis U.S. LLC
No Recall HistoryCurrently in Shortage
Plain English
Rifadin IV is a injection, powder, lyophilized, for solution containing rifampin at 600 mg/10mL, taken intravenous. Manufactured by Sanofi-Aventis U.S. LLC.
Key Facts
- Brand Name
- Rifadin IV
- Generic Name
- rifampin
- NDC Code (Product)
0068-0597- Manufacturer
- Sanofi-Aventis U.S. LLC
- Strength
- 600 mg/10mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA050627
- Marketing Start
- 05/25/1989
Recall History
No Recall HistoryFrequently Asked Questions
What is Rifadin IV used for?
Rifadin IV contains rifampin. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is Rifadin IV a controlled substance?
Rifadin IV is not classified as a controlled substance by the DEA.
What is the generic name for Rifadin IV?
The generic name for Rifadin IV is rifampin. There are 11 other brand versions of rifampin.
What is the NDC code for Rifadin IV 600 mg/10mL?
The NDC (National Drug Code) for Rifadin IV 600 mg/10mL is 0068-0597, listed by Sanofi-Aventis U.S. LLC.